3188 results for cancer and finances
Refine Your Search
Optimizing Clinical Outcomes in Blood Cancers through Groundbreaking Translational Research
This activity will provide learners with the latest developments in translational medicine for leukemia, lymphoma, and myeloma and how these developme…
LLS Unveils Name Change to Reach All Blood Cancer Patients
WASHINGTON, JULY , – The Leukemia & Lymphoma Society (LLS), the global nonprofit in funding blood cancer research, patient support and advocacy, is b…
News Release
Student Trailblazers, Part 2: leukemia survivor studies cancer’s impact on caregivers
- studies cancer's effects on caregivers
Blog
How to use creativity to cope with a blood cancer diagnosis
Photo credit: Sunny Shokrae There are more than types of blood cancer. There are infinitely more ways than that to process g…
Blog
Living with Acute Leukemia
Choosing a blood cancer specialist or treatment center for young adults
After receiving a blood cancer diagnosis, you will want to find a blood cancer specialist or choose a treatment center. Here’s how.
Support Resources
Barclays Ajay Kataria is on a Mission to End Blood Cancer
Congratulations to Ajay Kataria, Head of BARX FX Sales, Americas, who was just awarded the ‘Citizenship Achievement of the Year – Americas’ at Barclay…
Beyond the diagnosis: How employers can champion employees facing cancer
“When someone faces cancer, they shouldn't have to go it alone.” – Orlando Ashworth, CPO, LLS Cancer doesn’t just impact an individual. It sends rippl…
Education Resources
When Someone is Diagnosed with Blood Cancer, Every Minute Matters
When Someone is Diagnosed with Blood Cancer, Every Minute Matters
100 Blood Cancer Advocates Visit Washington, Urge Lawmakers to Act
For the first time in four years, blood cancer advocates convened in Washington, D.C. this spring. Together, they shared a single, critical purpose: t…
Relentless High School Students Forge Ahead for a Future Without Cancer
Thousands of high school students in hundreds of communities across the country have proven that nothing, not even a global pandemic, can stand in the…
Join LLS Partner, Triage Cancer, for the 2021 Webinar Series
LLS partner, Triage Cancer, is holding its webinar series now. Triage Cancer offers free educational webinars on practical and legal cancer survivors…
Philanthropic Powerhouses Remain Laser-Focused in Pursuit of a World without Cancer
The Leukemia & Lymphoma Society announces winners of Man & Woman of the Year fundraising competition
News Release
Affimed Presents Final Data Demonstrating Safety and Efficacy of AFM13 Phase 2 REDIRECT Study in Patients with Heavily Pretreated R/R PTCL at the American Association for Cancer Research Annual Meeting
Heidelberg, Germany, April , – Affimed N.V. (Nasdaq: AFMD), a company committed to giving patients back their innate ability to fight cancer, today…
Blood Cancer in the Black Community: Engaging in Your Health to Build a Better YOU!
Program detailsOwning your health is a powerful step toward breaking the cycles of disparity and building healthier communities. Join us for a program…
Novel CD7 CAR T-cells for refractory T-cell malignancies affecting pediatric and AYA patients
leukemias and lymphomas have devastating outcomes if they recur after or don’t respond to standard treatment, with the only hope of cure being bone ma…
She survived leukemia and now fights for the patients our healthcare system overlooks
Valerie Taylor nearly lost her life because she couldn’t afford the high cost of cancer care. Taylor—a volunteer and advocate—shares why she’s working…
Quality of Life, Outcomes, and Decision Making for Patients with Hairy Cell Leukemia
We aim to determine if rigorous assessment of quality of life (QOL) can help with treatment decisions for hairy cell leukemia (HCL). We will first ana…
A Message From Dr. Louis J. DeGennaro, President and CEO of The Leukemia & Lymphoma Society
One of the things that I value most about leading The Leukemia & Lymphoma Society (LLS) is seeing our talented, dedicated and relentless staff and vol…
Biomarker and Risk Tailored Treatment to Improve Outcomes in Diffuse Large B-cell Lymphoma
Improving survival for patients with diffuse large lymphoma requires tailoring treatment to lymphoma genetic heterogeneity, addressing minimal residu…
Uncovering immune evasion mechanisms and therapeutic targets in B-cell lymphomas via macrophage reprogramming
EZB lymphomas, driven by BCL2 translocations and EZH2 mutations, induce macrophages to adopt a supportive role, essential for maintaining the malignan…
Precision Targeting of Metabolism and Mitochondria for Chemotherapy Resistance in Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a heterogeneous group of diseases that require complex therapy and are difficult to cure. AML is caused by the accumu…
A Panel Discussion on Transitioning Your Student Back to School: Practical Tips and Advice
Watch this informative panel discussion of school personnel for practical tips on supporting a student attending school during or after cancer treatme…